Company Timeline

2021

  • February: FloBio secures exclusive worldwide license for novel IVD technology for bleeding and thrombotic risk
  • January: Ben Franklin invests in early-stage start ups

2020

  • November: NSF awards FloBio Phase 1 SBIR to further device design
  • October: FloBio is a 2020 Falling Walls Finalist for Science Startup Breakthrough of the Year
  • September: FioBio presents at BIO NJ
  • August: NIH awards FloBio Phase 1 SBIR to pursue its 2nd clinical application for neonates
  • May: FloBio presents at Med Tech Innovator
  • March: FloBio presents at PACT Capital Conference

2019

  • October: FloBio secures seed funding
  • September: FloBio presents at PACT Capital Conference
  • September: NIH awards FloBio Phase 1 SBIR to pursue development of its Point-of-Care Test for DOACs
  • March: FioBio awarded Pennsylvania Pediatric Consortium Grant

2018

  • August: FloBio hires Jerri Ann Thatcher as CEO

2017

  • August: FloBio spun out of the University of Pennsylvania and becomes a member of PCI Venture UPStart Incubator